Device Trial Radar · NCT01634620
Use of FeNO to Identify Eosinophilic Inflammation in Patients Age 40 Years and Above With Chronic Obstructive Airways Disease
Last checked: Nov 19, 2026Latest source record: Feb 12, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
200
Actual
Start
Jun 2012
Primary completion
Oct 2012
Study completion Oct 2012
Sponsor
- Lead sponsor
- Aerocrine ABNot on our public-company list
- Sponsor type
- Industry
- First posted
- Jul 6, 2012
Design
- Study type
- Observational
- Who can join
- All sexes, from 40 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Objective: To characterize FeNO levels that may be indicative of eosinophilic airway inflammation in patients with chronic obstructive airways disease Number of participants: Approximately 200 subjects will be enrolled Reference product: NIOX MINO® Instrument (09-1100) Performance assessments: Fractional Exhaled Nitric Oxide (FeNO) Measurements will be performed according to the "Perform FeNO Measurement" guidelines on page 7 of the NIOX MINO® User Manual Safety assessments: The Investigator is responsible for the detection, reporting, and documentation of events meeting the definition of an Adverse Event (AE) and/or Serious Injuries as provided in this clinical investigation plan from the time that informed consent has been provided and during the study period Criteria for evaluations: This is an observational, pilot study and there are currently no plans for a formal statistical analysis. Information gained from this study may used to design subsequent studies in patients with chronic obstructive airways disease. Information collected will be summarized in a clinical study report but will not be subject to formal hypothesis testing
Conditions
- Chronic Obstructive Pulmonary Disease (COPD)
Interventions
NIOX MINO® Instrument (09-1100)Device
FeNO measurements will be performed according to the "Perform FeNO Measurement" guidelines on page 7 of the NIOX MINO® User Manual (February, 2011)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Spirometry Results: FEV1 (L)Time frame: Single Visit
- Spirometry Results: FVC (L)Time frame: Single Visit
- Spirometry Results: FEV1 (% Predicted)Time frame: Single Visit
8 more outcomes with a free account
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
University of North Carolina Hospitals
Chapel Hill, North Carolina
University of North Carolina Hospitals - Sanford Specialty Clinics
Sanford, North Carolina
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.